image
Orchestra BioMed Holdings, Inc. OBIO
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 5.84
-5.96 %
$ 222 M
Market Cap
-3.74
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 -21.88% -46.16% -57.72%
Annual Report FY 10-K 2022-12-31 551.79% -46.03% -49.81%
Annual Report FY 10-K 2021-12-31 -13.71% -7.77% -16.25%
Annual Report FY 10-K 2020-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 135.56% -15.85% -12.52%
Quarterly Report Q2 8-K 2024-06-30 -14.97% -32.66% -30.13%
Quarterly Report Q1 8-K 2024-03-31 -46.74% -23.06% -24.93%
Quarterly Report Q4 8-K 2023-12-31 -76.25% -1362.04% -1323.60%
Quarterly Report Q3 8-K 2023-09-30 -63.97% -1841.70% -1685.55%
Quarterly Report Q2 8-K 2023-06-30 128.18% -53.51% -69.71%
Quarterly Report Q1 8-K 2023-03-31 34.41% -90.96% -125.14%
Quarterly Report Q4 8-K 2022-12-31 144.97% -896.15% -852.54%
Quarterly Report Q3 8-K 2022-09-30 -12.75% -658.53% -761.31%
Quarterly Report Q2 8-K 2022-06-30 141.00% -8398.95% -7825.66%
Quarterly Report Q1 8-K 2022-03-31 -34.19% -5204.53% -4480.62%
Quarterly Report Q4 8-K 2021-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2021-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2021-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2021-03-31 0.00% 0.00% 0.00%